5.245 şirket eşleşiyor
Showing 1.901–1.950 of 5.245
| Şirket | Not | Fiyat | Zirveden | F/K | Büyüklük | Verim | Opsiyonlar | Sektör |
|---|---|---|---|---|---|---|---|---|
| C | $12,80 | -%2 | 29,09 | $2,3B | %2,8 | Aylık | Reit Hotel and Motel | |
| B | $63,12 | -%36 | 40,99 | $2,3B | %1,1 | Aylık | Electronic Components | |
| F- | $16,26 | -%4 | — | $2,3B | %5,4 | Aylık | Drug Manufacturers Specialty and Generic | |
| D- | $7,53 | -%59 | — | $2,2B | — | Aylık | Software Application | |
| C+ | $43,63 | -%22 | 10,05 | $2,2B | %3,2 | Aylık | Apparel Retail | |
| A | $9,72 | -%36 | — | $2,2B | — | Aylık | Software Application | |
| D | $33,95 | -%2 | 6,24 | $2,2B | — | Aylık | Biotechnology | |
| Notsuz | $152,51 | -%13 | — | $2,2B | — | Aylık | Biotechnology | |
| C | $125,14 | -%25 | 50,06 | $2,2B | — | Aylık | Electronic Components | |
| D | $46,34 | -%68 | 81,29 | $2,2B | — | Aylık | Semiconductor Equipment and Materials | |
| C | $11,61 | -%35 | 32,25 | $2,2B | — | Aylık | Education and Training Services | |
| Notsuz | $17,75 | -%52 | — | $2,2B | — | Aylık | Other Precious Metals and Mining | |
| C | $62,18 | -%9 | 12,49 | $2,2B | %2,2 | Aylık | Banks Regional | |
| A+ | $15,13 | -%3 | 11,20 | $2,2B | %5,3 | Aylık | Banks Regional | |
| F | $21,44 | -%22 | 12,11 | $2,2B | — | Aylık | Luxury Goods | |
| C- | $29,49 | -%12 | — | $2,2B | — | Aylık | Health Information Services | |
| F | $18,74 | -%37 | — | $2,2B | — | Aylık | Biotechnology | |
| A | $17,34 | -%1 | — | $2,2B | — | Aylık | Software Application | |
| A | $39,83 | %0 | — | $2,2B | %4,0 | Aylık | Reit Industrial | |
| D | $21,83 | -%48 | 37,63 | $2,2B | — | Aylık | Utilities Regulated Gas | |
| F | $9,18 | -%45 | — | $2,2B | — | Aylık | Medical Care Facilities | |
| F | $52,12 | -%4 | 17,26 | $2,2B | %3,8 | Aylık | Utilities Regulated Gas | |
| F | $10,92 | -%13 | — | $2,2B | — | Aylık | Drug Manufacturers Specialty and Generic | |
| C+ | $46,17 | -%34 | 14,25 | $2,2B | — | Aylık | Drug Manufacturers Specialty and Generic | |
| C | $29,42 | -%25 | 9,28 | $2,2B | %3,7 | Aylık | Banks Regional | |
| Notsuz | $33,37 | -%14 | — | $2,2B | — | Aylık | Biotechnology | |
| Notsuz | $10,63 | -%51 | 9,23 | $2,2B | %4,0 | Aylık | Banks Regional | |
| C | $46,61 | -%26 | 18,42 | $2,2B | %3,1 | Aylık | Staffing and Employment Services | |
| Notsuz | $8,25 | -%65 | — | $2,2B | — | Aylık | Other Industrial Metals and Mining | |
| A | $21,20 | -%42 | 19,81 | $2,2B | — | Aylık | Oil Gas Equipment and Services | |
| B | $33,26 | -%25 | — | $2,2B | — | — | Insurance Brokers | |
| A+ | $51,65 | -%4 | 9,84 | $2,2B | %2,2 | Aylık | Banks Regional | |
| A | $53,00 | -%1 | 12,35 | $2,1B | %2,7 | Aylık | Insurance Property and Casualty | |
| Notsuz | $30,85 | -%19 | — | $2,1B | — | — | Medical Devices | |
| F | $103,83 | -%69 | — | $2,1B | — | Aylık | Uranium | |
| F | $13,06 | -%61 | 54,40 | $2,1B | %2,8 | Aylık | Oil Gas Equipment and Services | |
| C | $17,97 | -%6 | 40,84 | $2,1B | — | Aylık | Consumer Electronics | |
| A+ | $88,13 | -%2 | 12,11 | $2,1B | %2,0 | Aylık | Banks Regional | |
| F- | $17,41 | -%56 | — | $2,1B | %1,7 | Haftalık | Thermal Coal | |
| B | $13,56 | -%0 | 34,77 | $2,1B | — | Aylık | Advertising Agencies | |
| B- | $70,88 | -%26 | — | $2,1B | — | Aylık | Medical Devices | |
| C+ | $15,59 | -%15 | 11,99 | $2,1B | %2,4 | Aylık | Integrated Freight and Logistics | |
| F- | $4,91 | -%40 | — | $2,1B | — | Aylık | Apparel Manufacturing | |
| A+ | $15,73 | -%16 | 6,87 | $2,1B | — | Aylık | Biotechnology | |
| F | $6,75 | -%28 | 6,49 | $2,1B | %13,9 | Aylık | Credit Services | |
| C | $139,13 | -%33 | 40,44 | $2,1B | — | Aylık | Aerospace and Defense | |
| A | $55,41 | -%35 | 40,15 | $2,1B | — | Aylık | Communication Equipment | |
| D | $82,99 | -%13 | 20,49 | $2,1B | %0,9 | Aylık | Electronics and Computer Distribution | |
| A+ | $8,63 | -%60 | 4,36 | $2,1B | — | Haftalık | Solar | |
| Notsuz | $13,81 | -%19 | — | $2,1B | — | Aylık | Biotechnology |
Filtre bir tavsiye değildir. Her satır belirtilen koşulu sağladı, fazlasını değil — InspectStocks şirketleri kendi SEC raporlarından anlatır ve hiçbir şeyin alınmasını veya satılmasını önermez.